Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1662-1669

  Noordzij, Marlies ^a   Cranenburg, Ellen M ^b   Engelsman, Lyda F ^c   Hermans, Marc M ^d   Boeschoten, Elisabeth W ^c   Brandenburg, Vincent M ^e   Bos, Willem Jan W ^f   Kooman, Jeroen P ^d   Dekker, Friedo W ^g   Ketteler, Markus ^h   Schurgers, Leon J ^b   Krediet, Raymond T ^a   Korevaar, Johanna C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Hans Mak Institute   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Dialysis Centre   (Germany)

Author keywords

aortic calcification; calcium; haemodialysis; peritoneal dialysis; PTH

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AORTA; AORTA ARCH; ARTERY CALCIFICATION; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY;

AGED; AORTIC DISEASES; CALCINOSIS; CALCIUM; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MINERALS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL RATE;

EID: 79955624020     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq582     Document Type: Article

References (26)

1. Noordzij M, Korevaar JC, Bos WJ et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis pa-tients compared with haemodialysis patients. Nephrol Dial Trans-plant 2006; 21: 2513-2520 (Pubitemid 44644525)
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardio-vascular disease in chronic renal disease. Am JKidney Dis 1998; 32: S112-S119 (Pubitemid 28527268)
3. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mor-tality, and morbidity in maintenance hemodialysis. JAm Soc Nephrol 2004; 15: 2208-2218 (Pubitemid 39031360)
4. Young EW, Albert JM, Satayathum S et al. Predictors and conse-quences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study Kidney Int 2005; 67: 1179-1187 (Pubitemid 41623345)
5. Ganesh SK, Stack AG, Levin NW et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with car-diac mortality risk in chronic hemodialysis patients. JAm Soc Nephrol 2001; 12: 2131-2138 (Pubitemid 32880350)
6. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dia-lysis patients. Am JKidney Dis 1996; 27: 394?401
7. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcifi-cation in young adults with end-stage renal disease who are undergo-ing dialysis. NEngl JMed 2000; 342: 1478-1483 (Pubitemid 30318271)
8. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? JAm Coll Cardiol 2002; 39: 695-701 (Pubitemid 34158168)
9. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mor-tality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833 (Pubitemid 36331846)
10. Schurgers LJ, Teunissen KJ, Knapen MH et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25: 1629-1633 (Pubitemid 41098932)
11. Moe SM, O'Neill KD, Fineberg N et al. Assessment of vascular cal-cification in ESRD patients using spiral CT. Nephrol Dial Transplant 2003; 18: 1152-1158 (Pubitemid 36722518)
12. Jung HH, Kim SW, Han H. Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialy-sis. Nephrol Dial Transplant 2006; 21: 1915-1920 (Pubitemid 43985720)
13. Bellasi A, Ferramosca E, Muntner P et al. Correlation of simple im-aging tests and coronary artery calcium measured by computed tom-ography in hemodialysis patients. Kidney Int 2006; 70: 1623-1628 (Pubitemid 44606998)
14. van Dijk PC, Jager KJ, de Charro F et al. Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Trans-plant 2001; 16: 1120-1129 (Pubitemid 32547364)
15. Davies SJ, Russell L, Bryan J et al. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am JKidney Dis 1995; 26: 353-361
16. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am JKidney Dis 2003; 42: S1-S202
17. Portale AA. Blood calcium, phosphorus, and magnesium. In: MJ Favus (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th edn. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 1999; p115-p118
18. Hermans MM, Brandenburg V, Ketteler M et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007; 72: 202-207 (Pubitemid 47067382)
19. Hermans MM, Vermeer C, Kooman JP et al. Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and re-lated to parameters of calcium-phosphate metabolism and aortic aug-mentation index. Blood Purif 2007; 25: 395-01
20. Witteman JC, Kannel WB, Wolf PA et al. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 1990; 66: 1060-1064 (Pubitemid 20365357)
21. Hujairi NM, Afzali B, Goldsmith DJ. Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 2004; 43: 234-243 (Pubitemid 38146321)
22. Tripepi G, Jager KJ, Dekker FW et al. Bias in clinical research. Kidney Int 2008; 73: 148-153
23. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and cal-cium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824 (Pubitemid 43169927)
24. Stompor TP, Pasowicz M, Sulowicz W et al. Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis. Am JKidney Dis 2004; 44: 517-528 (Pubitemid 39164628)
25. Kauppila LI, Polak JF, Cupples LA et al. New indices to classify lo-cation, severity and progression of calcific lesions in the abdominal aorta: a25-yearfollow-up study. Atherosclerosis 1997; 132: 245-250 (Pubitemid 27311017)
26. Sigrist MK, Taal MW, Bungay P et al. Progressive vascular calcifica-tion over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin JAm Soc Nephrol 2007; 2: 1241-1248